PensionDanmark Pensionsforsikringsaktieselskab Has $11.09 Million Stock Holdings in Centene Corporation $CNC

PensionDanmark Pensionsforsikringsaktieselskab grew its stake in shares of Centene Corporation (NYSE:CNCFree Report) by 8.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 172,730 shares of the company’s stock after purchasing an additional 13,663 shares during the period. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Centene were worth $11,088,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of CNC. DV Equities LLC purchased a new stake in Centene during the fourth quarter valued at about $26,000. IFC & Insurance Marketing Inc. purchased a new position in shares of Centene in the fourth quarter worth approximately $28,000. SBI Securities Co. Ltd. raised its holdings in shares of Centene by 118.4% during the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock valued at $31,000 after acquiring an additional 406 shares during the period. Bayban purchased a new stake in shares of Centene in the 4th quarter valued at approximately $33,000. Finally, MV Capital Management Inc. acquired a new position in Centene in the 4th quarter worth approximately $34,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Trading Up 2.3%

NYSE CNC opened at $65.69 on Friday. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.71. Centene Corporation has a 1-year low of $25.18 and a 1-year high of $69.36. The firm’s fifty day simple moving average is $64.48 and its 200-day simple moving average is $50.92. The company has a market capitalization of $32.45 billion, a PE ratio of -6.29, a price-to-earnings-growth ratio of 0.34 and a beta of 1.08.

Centene (NYSE:CNCGet Free Report) last released its quarterly earnings data on Tuesday, July 28th. The company reported $2.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.09 by $1.42. Centene had a positive return on equity of 12.12% and a negative net margin of 2.51%.The firm had revenue of $53.58 billion during the quarter, compared to analysts’ expectations of $47.64 billion. During the same quarter last year, the firm earned ($0.16) earnings per share. The business’s revenue for the quarter was up 9.9% on a year-over-year basis. Centene has set its FY 2026 guidance at 4.800- EPS. As a group, sell-side analysts anticipate that Centene Corporation will post 4.89 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

CNC has been the topic of several recent analyst reports. JPMorgan Chase & Co. boosted their target price on shares of Centene from $60.00 to $67.00 and gave the company a “neutral” rating in a research note on Tuesday. Robert W. Baird lifted their price target on Centene from $46.00 to $66.00 and gave the company a “neutral” rating in a report on Wednesday, July 29th. Mizuho set a $63.00 price target on Centene and gave the company a “neutral” rating in a research report on Monday, June 8th. Barclays restated an “overweight” rating and set a $80.00 price objective (up from $75.00) on shares of Centene in a research report on Wednesday, July 29th. Finally, Oppenheimer lifted their target price on Centene from $58.00 to $67.00 and gave the company an “outperform” rating in a research note on Wednesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $68.58.

Check Out Our Latest Stock Analysis on CNC

Centene Profile

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

Featured Articles

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNCFree Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.